US Prepares for Possible Ground Troop Deployment in the Middle East
CNN's Kaitlin Collins Set Up Scott Jennings Perfectly to Torch the Biden Administration
My Word, Ms. Spanberger, What Fresh Hell Is This Tweet?
Victory for President Trump’s DOGE – ACLJ Amicus Brief Affirmed
Our Long Road to War With Iran
Did We Avoid Another Terrorist Attack This Week? This Arrest in Texas Makes...
Globalize the Intifada? Authorities in the Netherlands Are Investigating Fire at Synagogue
What Can We Do About Islam in America?
More Questions Have Surfaced About Eric Swalwell's Eligibility to Run for California Gover...
All It Took for Democrats to Cave on DHS Funding Was Four Terrorist...
Pete Hegseth Blasts Reports That the United States Did Not Plan on Iran...
All Six American Crewman Aboard Refueling Aircraft That Crashed in Iraq Confirmed Dead
Ex-Top Gun Pilot Says The Threat of Iranian Sleeper Cells 'Is Not a...
Even Obama's Former DHS Secretary Is Calling on Democrats to Fund DHS
California Scrambles to Bolster Drone Defenses After FBI Warns Iran May Target West...
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’
AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos